Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[F-18]FLT PET vs [F-18]FDG PET for Treatment Evaluation in Cancer
NCT00847509Phase 3Completed
- Sponsor
- Siemens AG
- Start
- Feb 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluorothymidine F-18 in lung cancer, head and neck cancer (HNC), sponsored by Siemens AG. Started Feb 2009; status: completed.
02
Drugs
fluorothymidine F-18
03
Conditions
lung cancerhead and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00847509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847509.